Apologies if it has already been asked or commented on (I couldn't make the call and am quickly scrolling through the threads), but was there any mention of Phase 3 trial for NNZ-2591 and the Type C meeting with the FDA.
One positive I am taking from the comments above is that they would partner at this stage ONLY if it was a knock out offer, so they must be pretty confident this meeting will go well.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.99 |
Change
0.030(0.23%) |
Mkt cap ! $1.615B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.70 | $1.733M | 134.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 722 | $12.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.01 | 45 | 3 |
View Market Depth
| Last trade - 12.15pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |